1. Home
  2. CWST vs CORT Comparison

CWST vs CORT Comparison

Compare CWST & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casella Waste Systems Inc.

CWST

Casella Waste Systems Inc.

HOLD

Current Price

$92.38

Market Cap

6.4B

Sector

Utilities

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$113.05

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CWST
CORT
Founded
1975
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
9.7B
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
CWST
CORT
Price
$92.38
$113.05
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
$115.71
$96.50
AVG Volume (30 Days)
433.8K
805.4K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$1,836,841,000.00
$761,407,000.00
Revenue This Year
$10.95
$26.08
Revenue Next Year
$6.97
$26.98
P/E Ratio
N/A
$1,259.44
Revenue Growth
17.95
12.79
52 Week Low
$74.05
$28.66
52 Week High
$107.96
$126.38

Technical Indicators

Market Signals
Indicator
CWST
CORT
Relative Strength Index (RSI) 50.81 51.71
Support Level $88.45 $77.73
Resistance Level $94.14 $122.21
Average True Range (ATR) 2.26 4.04
MACD 0.13 -1.68
Stochastic Oscillator 58.91 15.22

Price Performance

Historical Comparison
CWST
CORT

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: